Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Inflammatory Bowel Diseases 1 Crohn Disease 1 Colorectal Neoplasms 1 Colitis, Ulcerative 1

Interventions

Oxaliplatin 47 Capecitabine 46 Fluorouracil 40 Leucovorin 30 Radiotherapy 25 Irinotecan 20 Chemoradiotherapy 14 Bevacizumab 14 Cetuximab 12 Neoadjuvant Therapy 11 Folfox protocol 11 Chemotherapy, Adjuvant 11 XELOX 10 Laparoscopy 10 Drug Therapy 9 Surgical Procedures, Operative 6 Robotic Surgical Procedures 5 Radiation 5 Mastectomy, Segmental 5 Surveys and Questionnaires 4 Radiotherapy, Intensity-Modulated 4 Panitumumab 4 Gemcitabine 4 FOLFOXIRI protocol 4 durvalumab 3 Simvastatin 3 Magnetic Resonance Spectroscopy 3 Indocyanine Green 3 tislelizumab 2 regorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Rectal Neoplasms × Proctocolectomy, Restorative × Clear all

NCT04659148 2020-12-09

UC-RectalK

Istituto Clinico Humanitas

Gastrointestinal

Colitis, Ulcerative, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡